Roundtable Discussion: Masterminding Mitochondrial Drug Development for Multiple Disease Indications
Time: 1:30 pm
day: Day Two
Details:
Join tables led by mitochondrial drug development experts to discuss the benefits and challenges of different mitochondrial modulation strategies for rare and prevalent disorders.
- Debating methods of modulation to inform early mitochondrial drug development decisions
- Balance the distinct safety and clinical considerations of rare and prevalent diseases in relation to modality for regulatory success
